Aptorum Group Enters Into Material Transfer and Exclusive Option-To-License Agreement with Yale University for Its Novel Immunomodulators Potentially Targeting Autoimmune and Oncology Diseases
Go back to Aptorum Group Enters Into Material Transfer and Exclusive Option-To-License Agreement with Yale University for Its Novel Immunomodulators Potentially Targeting Autoimmune and Oncology Diseases| Plan A Promotions, Inc. (NASDAQ: APM) | Delayed: 5.48 -0.08 (1.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.56 | 52 Week High | $0.25 | |||
| Open | $5.60 | 52 Week Low | $0.25 | |||
| Day High | $5.68 | P/E | N/A | |||
| Day Low | $5.40 | EPS | $0.00 | |||
| Volume | 39,315 | |||||
| Plan A Promotions, Inc. (NASDAQ: APM) | Delayed: 5.48 -0.08 (1.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.56 | 52 Week High | $0.25 | |||
| Open | $5.60 | 52 Week Low | $0.25 | |||
| Day High | $5.68 | P/E | N/A | |||
| Day Low | $5.40 | EPS | $0.00 | |||
| Volume | 39,315 | |||||
